Skip to main content
OpenTrials

Clinical trial condition

Platinum-resistant Ovarian Cancer

Explore clinical trials studying Platinum-resistant Ovarian Cancer. Study availability and eligibility vary by location and protocol.

26 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Platinum-resistant Ovarian Cancer trial results

Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT06586957

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations
  • University of Arkansas Medical School Little Rock, Arkansas, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
View all 19 locations
View Trial Details
Recruiting

A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

NCT06547840

Conditions
Advanced Endometrial Cancer, Advanced Ovarian Cancer, Breast Diseases, +20 more
Locations
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Edinburgh Cancer Research Centre Edinburgh, United Kingdom
  • Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
  • Cambridge University - Addenbrooke's Hospital London, United Kingdom
View Trial Details
Active, not recruiting

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

NCT05081609

Conditions
2L+ Cervical Cancer, Advanced Solid Tumor, Female Urogenital Diseases, +27 more
Locations
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Springfield, Illinois, United States
  • Ascendis Pharma Investigational Site Louisville, Kentucky, United States
View all 68 locations
View Trial Details
Active, not recruiting

Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer

NCT06619236

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Arizona Center for Cancer Care (ACCC) - Biltmore Scottsdale, Arizona, United States
  • University of Arizona Cancer Center - Research and Administration at Main Campus Tucson, Arizona, United States
  • Providence Saint Joseph Medical Center - Roy and Patricia Disney Family Cancer Center Burbank, California, United States
View all 177 locations
View Trial Details
Active, not recruiting

Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)

NCT07109414

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • HonorHealth Cancer Care Phoenix, Arizona, United States
  • Trials365 Shreveport, Louisiana, United States
  • Optimum Clinical Research Group, LLC Albuquerque, New Mexico, United States
  • University of Pennsylvania Health System, Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

NCT03949283

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Kaiser Permanente Los Angeles, California, United States
  • Miami Cancer Institute/Baptist Health South Florida Miami, Florida, United States
  • LSU Health Sciences Center New Orleans, Louisiana, United States
  • University of Cincinnati Cancer Institute Cincinnati, Ohio, United States
View Trial Details

Related conditions